Gösterge TablosuPortföylerİzleme ListesiToplulukKeşfedinScreener
NOT FOR DISTRIBUTION

Evonik Industries AG

XTRA:EVK Stok Raporu

Piyasa değeri: €8.1b

  • Şirkete Genel Bakış
    • Değerleme
    • Gelecekteki Büyüme
    • Geçmiş Performans
    • Finansal Sağlık
    • Temettü
  • Yönetim
  • Sahiplik
  • Diğer Bilgiler
  • Hisse Senedi Topluluğu

Evonik Industries Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Evonik Industries şirketinin kazançları yıllık ortalama -31.3% oranında azalırken, Chemicals sektörünün kazançları yıllık 3.5% oranında azalan oldu. Gelirler yıllık ortalama 2.4% oranında azalan oldu. Evonik Industries şirketinin öz sermaye getirisi 1.7% olup, net marjı 0.9% dir.

Anahtar bilgiler

-31.25%

Kazanç büyüme oranı

-31.23%

EPS büyüme oranı

Chemicals Sektör Büyümesi12.41%
Gelir büyüme oranı-2.37%
Özkaynak getirisi1.66%
Net Marj0.86%
Sonraki Kazanç Güncellemesi03 Nov 2026

Yakın geçmiş performans güncellemeleri

Analiz Makalesi • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

Recent updates

User avatar
Anlatı Güncellemesi • Sep 03

EVK: Execution On New Capacity Investments Is Expected To Support Re Rating

Analysts raised their fair value estimate for Evonik Industries to €22 from €21, citing recent price target increases from several banks and updated assumptions around revenue growth, profit margins and future P/E multiples. Analyst Commentary on Evonik Industries Recent research on Evonik Industries points to a more constructive tone, with several bullish analysts lifting their fair value assumptions and price targets.
User avatar
Anlatı Güncellemesi • Aug 19

EVK: Fair Value View Weighs Q2 EBITDA Support Against Sector Headwinds

Analysts have modestly raised the fair value estimate for Evonik Industries from €17.78 to €18.28. The new estimate reflects a balance of higher Street price targets from banks, which are setting levels between €17 and €20, and more cautious views that point to structural and cyclical headwinds in the European chemicals sector.
Analiz Makalesi • Aug 07

Here's What Analysts Are Forecasting For Evonik Industries AG (ETR:EVK) After Its Second-Quarter Results

It's been a good week for Evonik Industries AG ( ETR:EVK ) shareholders, because the company has just released its...
User avatar
Anlatı Güncellemesi • Aug 05

EVK: Defensive Demand And Product Mix Are Expected To Support Re Rating

The updated fair value estimate for Evonik Industries moves to €21.0 from €20.4, with analysts pointing to recent price target increases across several banks and mixed rating changes that reflect differing views on earnings resilience, cost pressures and demand quality across the chemicals sector. Analyst Commentary Recent research on Evonik Industries shows a split view, although bullish analysts continue to highlight upside drivers that they see as underappreciated.
User avatar
Anlatı Güncellemesi • Jul 17

EVK: Fair Value View Balances Defensive Demand With Mixed Rating Shifts

The updated analyst price target framework for Evonik Industries edges higher to about €17.78. This reflects a modest adjustment in fair value, a slightly lower discount rate, and broadly stable growth and margin assumptions as analysts balance recent target raises with more cautious sector calls.
User avatar
Anlatı Güncellemesi • Jun 26

EVK: Restructuring And Polyester Exit Will Constrain Future Earnings Delivery

Analysts have raised the fair value estimate for Evonik Industries to €14.00 from €12.20. This change reflects updated assessments of revenue, margins and discount rates following a combination of higher price targets and rating changes in recent research reports.
Analiz Makalesi • Jun 20

Evonik Industries (XTRA:EVK) Stock Could Be 6.7% Undervalued After Efficiency Plan

Evonik Industries (XTRA:EVK) has introduced a new efficiency plan that includes 3,200 job cuts by 2029 and an exit from its loss-making global polyester business, drawing fresh attention to the stock. See our latest analysis for Evonik Industries. The efficiency plan has arrived after a mixed period for Evonik Industries, with the 1-day share price return of 5.24% and 90-day share price return of 15.35% contrasting with a 1-year total shareholder return that is down 5.40%. This suggests...
User avatar
Anlatı Güncellemesi • Jun 12

EVK: Methionine Pricing And Defensive Demand May Support Medium Term Re Rating

Analysts have raised the average price target for Evonik Industries to €20, up from the previous range of €17 to €19 in recent reports, reflecting updated views on earnings resilience, methionine pricing and defensiveness within European chemicals. Analyst Commentary The latest Street research on Evonik Industries presents a mixed picture, with both upgrades and downgrades across major brokers.
User avatar
Anlatı Güncellemesi • May 29

EVK: Balanced Outlook As Rating Shifts And Defensive Demand Shape Future Performance

Analysts have lifted the fair value estimate for Evonik Industries from €16.16 to €17.23. This change reflects a mix of higher price targets across the Street, ongoing concerns about mid term earnings and returns, and support from factors such as elevated methionine spreads and what analysts describe as more defensive demand.
Analiz Makalesi • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
User avatar
Anlatı Güncellemesi • May 03

EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re Rating

Analysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.
User avatar
Anlatı Güncellemesi • Apr 19

EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating Potential

Analysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.
User avatar
Anlatı Güncellemesi • Apr 03

EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share Performance

Analysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.
User avatar
Anlatı Güncellemesi • Mar 20

EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating Potential

The analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.
User avatar
Anlatı Güncellemesi • Mar 06

EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker Views

Analysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.
User avatar
Anlatı Güncellemesi • Feb 20

EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
User avatar
Anlatı Güncellemesi • Feb 06

EVK: Weaker Pricing Power Will Drive Lower Future Earnings Expectations

Analysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.
Analiz Makalesi • Feb 06

Evonik Industries AG (ETR:EVK) Not Flying Under The Radar

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
User avatar
Anlatı Güncellemesi • Jan 23

EVK: Sector Caution And Margin Execution Will Shape Future Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.
User avatar
Anlatı Güncellemesi • Jan 08

EVK: Pricing And Volume Execution Risk Will Pressure Future Earnings

Analysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
User avatar
Anlatı Güncellemesi • Dec 23

EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside Potential

Evonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
User avatar
Anlatı Güncellemesi • Dec 09

EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside Potential

The analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.
Analiz Makalesi • Dec 04

Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
User avatar
Anlatı Güncellemesi • Nov 24

EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform Collaboration

Evonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.
User avatar
Anlatı Güncellemesi • Nov 06

EVK: Resilience And New Partnerships Will Drive Improved Revenue Outlook

Evonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.
Analiz Makalesi • Oct 30

Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of Investors

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
User avatar
Anlatı Güncellemesi • Oct 23

Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic Moves

Evonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.
User avatar
Anlatı Güncellemesi • Oct 09

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.
User avatar
Anlatı Güncellemesi • Sep 25

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.
User avatar
Anlatı Güncellemesi • Sep 04

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

With both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.
User avatar
Yeni Anlatı • Nov 25

Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors

Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins.

Gelir ve Gider Dağılımı

Evonik Industries nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

XTRA:EVK Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2614,1121212,196398
31 Mar 2613,7191572,160407
31 Dec 2514,0692652,207419
30 Sep 2514,265942,041436
30 Jun 2514,7074232,324437
31 Mar 2515,1382992,374442
31 Dec 2415,1572222,396447
30 Sep 2415,1632292,577424
30 Jun 2415,102-902,310434
31 Mar 2415,058-3562,301431
31 Dec 2315,267-4652,315433
30 Sep 2316,002-6042,371455
30 Jun 2317,109-2952,541455
31 Mar 2317,9952722,560461
31 Dec 2218,4885392,566460
30 Sep 2218,2389262,561471
30 Jun 2217,2319442,457474
31 Mar 2216,0958692,348472
31 Dec 2114,9557482,253464
30 Sep 2114,0787242,186449
30 Jun 2113,1246422,068435
31 Mar 2112,3145462,030428
31 Dec 2012,1994892,022433
30 Sep 2012,2706142,011430
30 Jun 2012,5856172,045433
31 Mar 2013,0656792,070430
31 Dec 1913,1087532,079428
30 Sep 1913,0845062,111437
30 Jun 1913,1996242,139435
31 Mar 1913,3066732,163443
31 Dec 1813,2676862,162437
30 Sep 1813,5808412,238446
30 Jun 1813,7897972,293457
31 Mar 1813,9947882,353467
31 Dec 1714,3837132,409476
30 Sep 1714,0157232,365462
30 Jun 1713,6237182,321455
31 Mar 1713,2626562,273445
31 Dec 1612,7327482,201438
30 Sep 1612,7257582,180448
30 Jun 1612,9267252,154441
31 Mar 1613,1889812,150436
31 Dec 1513,5071,0082,140434
30 Sep 1513,5351,0272,176416

Kaliteli Kazançlar: EVK büyük bir tek seferlik zarar ile €499.0M, 30th June, 2026 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: EVK 'nin mevcut net kar marjları (0.9%) geçen yılın (2.9%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: EVK şirketinin kazançları son 5 yılda yılda 31.3% oranında azaldı.

Büyüme Hızlandırma: EVK 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: EVK geçtiğimiz yıl negatif kazanç büyümesine ( -71.4% ) sahipti ve bu da onu Chemicals sektör ortalamasıyla ( -13.3% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: EVK 'nin Özsermaye Getirisi ( 1.7% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/09/18 17:20
Gün Sonu Hisse Fiyatı2026/09/18 00:00
Kazançlar2026/06/30
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
  • SEC Form 10-K
  • SEC Form 10-Q
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
  • Analist Araştırma Raporları
  • Blue Matrix
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
  • ICE Piyasa Verileri
  • SEC Form S-1
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
  • SEC Form 4
  • SEC Form 13D
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
  • SEC Form 10-K
  • SEC Form DEF 14A
Önemli Gelişmeler10 yıl
  • Şirket duyuruları
  • SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Evonik Industries AG 30 Bu analistlerden 12, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Anil ShenoyBarclays
Andreas HeineBarclays
Sebastian BrayBerenberg

Her Yerde Daha İyi Yatırım Kararları Alın

İndirmek için tarayın
AppStore’u AçGoogle Play’i Aç
Chrome Web Mağazası
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Veri Kaynaklarını Görüntüle
Piyasalar
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Yatırım Fikirleri
  • Değeri Düşük Şirketler
  • Temettü Santralleri
  • İçeriden Satın Alma
  • Nükleer Enerji
  • Otonom Araçlar
  • Yapay Zeka
  • Kripto ve Blok Zinciri
  • Siber güvenlik
  • Daha fazla fikir
Hisse Toplulukları
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Araçlar ve özellikler
  • Portföy Takibi
  • Hisse Senedi Tarayıcı & Uyarılar
  • Anlatılar ve Adil Değerler
  • Temettü Hesaplayıcı
Haberler ve Keşifler
  • Son Hisse Senedi Haberleri
  • Küresel Pazar İçgörüleri
  • Foxhole
  • Yatırım Fikirleri
  • Topluluk Anlatıları
  • Yenilikler
Simply Wall St
  • Planlar & Fiyatlandırma
  • Reklam
  • Hakkımızda
  • Bize Ulaşın
  • Kariyer
  • Yardım Merkezi
  • Hisse Senedi Yatırımını Öğrenin
  • Ortaklık Programı
  • İşletme ve Kurumsal
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Şartlar ve Koşullar
  • Gizlilik Politikası
  • Yapay Zeka Koşulları
  • Finansal Hizmetler Rehberi